file8k.htm

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
________________
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of Earliest Event Reported) – August 5, 2008
 
________________________
 
WEST PHARMACEUTICAL SERVICES, INC.

(Exact name of registrant as specified in its charter)
 
_____________________


     
Pennsylvania
1-8036
23-1210010
(State or other jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
     
101 Gordon Drive, PO Box 645, Lionville, PA
  
19341-0645
(Address of principal executive offices)
  
(Zip Code)

 
(610) 594-2900
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or address, if changed since last report)
____________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02
Results of Operations and Financial Condition
   
 
On August 5, 2008, West Pharmaceutical Services, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the second quarter ended June 30, 2008. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
   
Item 9.01
Financial Statements, Pro Forma Financial Information and Exhibits.
   
(c)
Exhibits
   
 
Exhibit #
Description
 
99.1
West Pharmaceutical Services, Inc. Press Release, dated August 5, 2008.
 

 

 
 

 

 
 
 

 

 
 
SIGNATURE
 
 

 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
WEST PHARMACEUTICAL SERVICES, INC.
 
 
/s/ William J. Federici
William J. Federici
Vice President and Chief Financial Officer

 
 
 

 
 
August 5, 2008
 

 
 
 
 
 
EXHIBIT INDEX
 
 
Description
 
 

 
 
99.1           West Pharmaceutical Services, Inc. Press Release, dated August 5, 2008.